Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Feb;8(1):64-72.
doi: 10.1007/s13346-017-0434-z.

Ion-pair formation combined with a penetration enhancer as a dual strategy to improve the transdermal delivery of meloxicam

Qikun Jiang  1 , Jin Wang  1 , Panqin Ma  2 , Cuiru Liu  1 , Mengchi Sun  1 , Yinghua Sun  3 , Zhonggui He  4
Affiliations

Ion-pair formation combined with a penetration enhancer as a dual strategy to improve the transdermal delivery of meloxicam

Qikun Jiang et al. Drug Deliv Transl Res. 2018 Feb.

Abstract

The aim of the study was to develop a novel drug-in-adhesive patch for transdermal delivery of meloxicam (MLX). The formulation involved a strategy to combine a chemical enhancer with an ion-pair agent. Diethylamine (DETA) was selected as the counter ion to form the ion-pair agent MLX-DETA. MLX-DETA was characterized by nuclear magnetic resonance spectroscopy (NMR) and Fourier transform infrared spectroscopy (FTIR). The ion-pair lifetime (T life) of MLX-DETA was 164.1 μs. The water solubility of MLX-DETA was increased nearly 9.3-fold, compared with that of MLX. Oleic acid (OA) was selected as the chemical enhancer, and the optimized formulation consisted of 5% (w/w) MLX-DETA, 5% (w/w) oleic acid, and DURO-TAK® 87-4098 adhesive as the pressure-sensitive adhesive matrix. The permeation study in vitro showed that both the counter ion and chemical enhancer were effective in improving the skin permeation of MLX. Tissue distribution studies demonstrated that higher accumulation of MLX following application of the MLX-DETA patch to the skin could be obtained in rats compared with the MLX-patch group. In conclusion, to increase the skin absorption and obtain a sustained release for the transdermal delivery of MLX, preparation of a drug-in-adhesive patch by combining an ion pair (MLX-DETA) with a permeation enhancer (OA) is a suitable strategy.

Keywords: Ion-pair formation; Meloxicam; Permeation enhancer; Tissue distribution; Transdermal drug delivery.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Engelhardt G. Pharmacology of meloxicam, a new non-steroidal anti-inflammatory drug with an improved safety profile through preferential inhibition of COX-2. Br J Rheumatol. 1996;35(Suppl 1):4–12. - DOI - PubMed
    1. Noble S, Balfour JA. Meloxicam. Drugs. 1996;51(3):424–30. discussion 431-432 - DOI - PubMed
    1. Alomrani AH, Badran MM. Flexosomes for transdermal delivery of meloxicam: characterization and antiinflammatory activity. Artif Cells Nanomed Biotechnol. 2016;28:1–8.
    1. Chang JS, Huang YB, Hou SS, Wang RJ, Wu PC, Tsai YH. Formulation optimization of meloxicam sodium gel using response surface methodology. Int J Pharm. 2007;338(1–2):48–54. - DOI - PubMed
    1. Engelhardt G, Homma D, Schlegel K, Utzmann R, Schnitzler C. Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance. Inflamm Res. 1995;44(10):423–33. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources